When your Doctor makes the switch, it’s often for a good reason. Please watch and share 🙏🏿.

A poor erection could be a sign of a bigger issue. Please watch and share 🙏🏿.

It depends on the specific generic you’re using. There are brands that come very close to Rocephin, if not being equivalent to it. Some multinational pharmaceutical companies also manufacture generic products that are equipotent to pioneer brands. The term generic covers a much broader spectrum than many people realise. Roche can be the pioneer brand for one molecule and a generic manufacturer for another. The same applies to GSK and Sanofi. Does that mean the brand Roche is generic for is inferior? Generic brands are not exclusive to indigenous pharmaceutical companies. Even multinational pharmaceutical companies manufacture generics. In some cases, the same pharmaceutical company can market both a pioneer brand and a generic version of the same product. Augmentin and Clavulin are examples often cited in this context. Both are associated with GSK, yet Clavulin is a more affordable alternative to Augmentin. The point is that generic medicines are not necessarily inferior simply because they are generics, nor are they exclusively produced by local manufacturers. If you don’t speak to a pharmacist, you won’t grasp some of these things.

It’s better to compare brands based on evidence of efficacy and quality rather than price alone. Innovator brands invest millions, sometimes billions, in discovering new molecules, conducting clinical trials across multiple phases, and monitoring safety after launch. This process can take 10–15 years, and even with patent protection, some companies never recover their investment because of failed trials and unsuccessful products. Generic manufacturers can then rely on the innovator’s published research and established evidence to develop equivalent products, often at a much lower cost, while meeting the required quality and bioequivalence standards. Brand pricing can also influence perception. Imagine Augmentin suddenly dropping to ₦2,500–₦3,000. Many people might feel they had been overcharged and switch to generics, without understanding the research costs and failed investments that may contribute to the original pricing. This is part of why discovering new molecules is so difficult for local pharmaceutical industries. Drug discovery requires substantial capital, research infrastructure, and long-term investment, often with government or institutional support. Without that capacity, many companies focus on compounding, manufacturing existing formulations, and rebranding rather than developing entirely new molecules.

The other doctor is talking about branded and generic products, while you’re talking about purchasing prescription-only medications without a proper prescription. These are two entirely different issues. The pharmacist is not wrong. When the NDLEA carries out operations against community pharmacies, they sometimes use agents who pose as doctors or pharmacists to test whether these establishments comply with regulations. A WhatsApp text message is not a prescription. A verbal request is not a prescription either. A valid prescription has specific requirements, including the hospital’s letterhead, the prescriber’s signature, a valid date, and other details pharmacists are trained to verify. Depending on the applicable requirements, the dispensing pharmacist is also expected to retain the original prescription or a copy, alongside the necessary documentation in the poison register, where applicable. The fact that other pharmacies have dispensed the medication to you without these requirements being met may simply be an act of professional courtesy, but that does not automatically make the practice right. We need to separate what we want from what the law and professional standards require. This really isn’t that complicated to understand…and please stop embarrassing yourself on the TL.

To celebrate world polio day. Please watch and share 🙏🏿.

Most pharmacists can see where he is coming from. And to be honest, his analysis is not entirely wrong. If every brand of a medication circulating in our market were truly equivalent in quality and therapeutic performance, doctors would have less reason to insist on specific brands and could prescribe more confidently using generic names alone. Unfortunately, that is not always the reality. This is one reason you need a trusted pharmacist and a trusted pharmacy to handle your prescriptions. However, the real issue here is not whether Rocephin is the best brand of ceftriaxone or the only brand a particular doctor trusts. The bigger issue is the lack of communication between the prescribing doctor and the dispensing pharmacist. Several factors influence the choice of medication and brand, including: The doctor’s knowledge of available brands and their expected quality. The severity of the patient’s condition, which may influence the need for reliable and predictable therapeutic outcomes. The patient’s affordability and ability to sustain the prescribed treatment. The availability of the prescribed medication at the time of dispensing. I have made a post and a video highlighting similar challenges within our healthcare system. Drug selection is not always as straightforward as people assume; the factors involved can be quite complex. Sometimes, a doctor prescribes a brand with a stronger reputation for quality. Sometimes, a more affordable alternative may be appropriate. In other situations, the patient cannot afford the prescribed brand, the brand is unavailable, or there may be legitimate concerns about the quality of an alternative. The solution is not for the pharmacist to blindly substitute or for the doctor to insist on a brand without considering the circumstances. Where a substitution becomes necessary because of cost, availability or concerns about quality, the prescribing doctor should be informed, particularly where the change could affect treatment. The pharmacist should also be able to explain and defend their recommendation, and the doctor should be willing to consider it. Ultimately, the doctor and pharmacist should work together in the patient’s best interest. Neither profession should operate in isolation when a patient’s treatment is at stake. The goal is not to defend a particular brand or professional ego. The goal is to ensure that the patient receives safe, effective, appropriate and affordable treatment.